EcoDrugPlus

Ensembl ID : ENSOMYG00000040336
Gene Symbol: -
Cross references: -
88 Possible Orthologues:

Ensembl ID : ENSOMYG00000022526
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSOMYG00000041052
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSOMYG00000041123
Gene Symbol: -
Cross references: -
331 Possible Orthologues:

Ensembl ID : ENSOMYG00000022478
Gene Symbol: -
Cross references: -
129 Possible Orthologues:

Ensembl ID : ENSOMYG00000022405
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSOMYG00000041403
Gene Symbol: -
Cross references: -
55 Possible Orthologues:

Ensembl ID : ENSOMYG00000042171
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSOMYG00000042365
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSOMYG00000042585
Gene Symbol: -
Cross references: -
95 Possible Orthologues:

Ensembl ID : ENSOMYG00000043422
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSOMYG00000043543
Gene Symbol: -
Cross references: -
158 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).